Many people with Parkinson's disease eventually develop debilitating movements called dyskinesia, a side effect of their much-needed dopamine replacement medication. The mechanism underlying this ...

An incisionless surgical procedure that uses focused ultrasound ablation (FUSA) to target the globus pallidus internus of patients with Parkinson's disease (PD) significantly reduced tremors and ...

Low-frequency transcranial stimulation of the pre-supplementary motor area was found to delay the onset and reduce severity of levodopa-induced dyskinesia in patients with Parkinson disease.

Northwestern Medicine scientists have discovered that suppressing excitatory synaptic transmission in a small group of neurons in the brain may reverse levodopa-induced dyskinesia in patients with ...

PD affects an estimated 1 million people in the United States, with approximately 60,000 people newly diagnosed each year. 1 The prevalence increases with age, and because of the growing aging ...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exclusive licensing agreement with Toray to develop ...

In our Medical Myths series, we approach medical misinformation head on. Using expert insight and peer reviewed research to wrestle fact from fiction, MNT brings clarity to the myth riddled world of ...

Symptoms of Parkinson’s disease can affect your daily life and well-being. Gocovri (amantadine) is a medicine used to manage uncontrolled movements in people taking a medicine called levodopa for ...

Share on Pinterest Scientists have found a novel method that may prevent a side effect of certain Parkinson’s therapies. Rob and Julia Campbell/Stocksy Researchers at the University of Alabama in ...

The mechanism underlying Parkinson's dyskinesia has been unknown, until now. An international collaboration has found a key cause, and with it, potentially, a new route to providing relief. Many ...